Evidence map›Paper›PMID 40826191›Full record

ArticleInternal and emergency medicine2025

Missed diagnosis rate of portal venous system thrombosis in cirrhosis on contrast-enhanced CT scans: Review of radiology reports from a tertiary hospital.

Siqi Jia, Huiyuan Lu, Ting Wang, Wenhui Huo, Zhuang Liu, Yueying Shi, Libo Zhang, Xingshun Qi

Abstract read
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Siqi Jia *Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.
Huiyuan Lu *Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.
Ting Wang *Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.
Wenhui Huo *Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.
Zhuang LiuLiver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.
Yueying ShiLiver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.
Libo ZhangDepartment of Radiology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China. zlb19782002@163.com.
Xingshun QiLiver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China. xingshunqi@126.com.ORCID 0000-0002-9448-6739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Portal venous system thrombosis (PVST) negatively influences the outcomes of cirrhotic patients. Its accurate diagnosis is essential for treatment selection and prognostic assessment, but it is usually missed in clinical practice. Overall, 684 contrast-enhanced computed tomography (CE-CT) scans were performed in cirrhotic patients who were consecutively admitted from January 2015 to June 2023, and were retrospectively reviewed by two independent researchers. Weighted-kappa was calculated to estimate the consistency of the two researchers in the diagnosis of PVST. If their conclusions were inconsistent, a senior researcher would be invited to make a final diagnosis. Clinically significant PVST (CSPVST) was further identified. By comparing the researchers' diagnosis with the radiology reports, the missed diagnosis rate of PVST was calculated. The Kappa coefficient was 0.85, indicating almost perfect consistency in the diagnosis of PVST between the two researchers. In total, PVST was diagnosed by the researchers on 278 (40.64%) of the 684 scans; and among them, a diagnosis of PVST was not recorded in 168 radiology reports. Thus, the missed diagnosis rate of PVST was 60.43% (168/278). CSPVST was diagnosed by the researchers on 87 (12.72%) scans; and among them, a diagnosis of PVST was not recorded in 38 radiology reports. Thus, the missed diagnosis rate of CSPVST was 43.68% (38/87). If a diagnosis of PVST was made only according to the radiology reports, a very high proportion of PVST would be missed. Considering a high rate of PVST detection in cirrhosis, the radiologists should pay more attention to the diagnosis of PVST, especially CSPVST.

Indexed as

Liver CirrhosisMissed DiagnosisPortal VeinTomography, X-Ray ComputedVenous ThrombosisAdultAgedContrast MediaFemaleHumansMaleMiddle AgedRetrospective StudiesTertiary Care CentersContrast MediaCirrhosisCTMisdiagnosisMissed diagnosisPortal veinThrombosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.